Results 211 to 220 of about 44,922 (302)

Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Emerging studies indicate that microbes are present in tumor cells and immune cells. Intratumoral microbiota (ITM) constitute an important component of the tumor immune microenvironment (TIME) and have an important impact on tumor progression and treatment. Objective Through the general elaboration of ITM represented by bacteria and
Fengxue Li, Lili Qiao, Xinquan Liang, Yingying Zhang, Ning Liang, Jian Xie, Guodong Deng, Yuying Hao, Pingping Hu, Xue Wu, Fangjie Ding, Can Feng, Yiming Mu, Jiandong Zhang   +13 more
wiley   +1 more source

Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study. [PDF]

Curr Urol
Krakhotkin D, Iglovikov N, Blecher G, Chernylovskyi V, Greco F, Gayvoronskaya SA, El Meliegy A.   +6 more
europepmc   +1 more source

Beyond bacterial defences: the role of lysozyme in cancer

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang, Qian Dong, Fuchu He, Zhiwen Gu, Aihua Sun   +4 more
wiley   +1 more source

Effects of the combination of anti-PcrV antibody and bacteriophage therapy in a mouse model of Pseudomonas aeruginosa pneumonia. [PDF]

Microbiol Spectr
Junya O, Jumpei F, Kinoshita M, Sudo K, Kawaguchi K, Inoue K, Naito Y, Moriyama K, Nakamura T, Iwano H, Sawa T.   +10 more
europepmc   +1 more source

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis. [PDF]

Sci Rep
Harker SA, Preissner M, Chang RY, Trevascus D, Liu C, Wang Y, Chow MYT, Cmielewski P, Reyne N, How YY, Pollock JA, Klein M, Wright CA, Dubsky S, Donnelley M, Chan HK, Morgan KS.   +16 more
europepmc   +2 more sources

Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspective. [PDF]

Front Cell Infect Microbiol
Bessems L, Chen B, Uyttebroek S, Devolder D, Lood C, Verwimp S, De Munter P, Debaveye Y, Depypere M, Spriet I, Van Gerven L, Dupont L, Wagemans J, van Noort V, Lavigne R, Metsemakers WJ, Onsea J.   +16 more
europepmc   +1 more source

Microbial‐Immune Interplay in CNS Autoimmune Diseases: Lessons from Animal Models and Clinical Studies

European Journal of Immunology, Volume 56, Issue 2, February 2026.
Mechanism of action of the intestinal microbiota on CNS autoimmune diseases. Environmental factors shape gut microbiota composition; dysbiosis alters microbial metabolites and antigenic signals. These modulate innate and adaptive immunity, affect barrier integrity, and influence CNS‐resident cells such as microglia and astrocytes, contributing to ...
Matteo Ceccon, Francesca Ronchi
wiley   +1 more source

A Case of Persistent Intra-Abdominal <i>Stenotrophomonas maltophilia</i> Infection Despite Bacteriophage Therapy. [PDF]

Phage (New Rochelle)
Cullen GD, Salazar KC, Terwilliger AL, Aslam S, Clark JR, Maresso AW, Bollyky PL, Aronson JR.   +7 more
europepmc   +1 more source

Nexus of Whey Proteins, Gut Dysbiosis, and Colonic Health

Food Science &Nutrition, Volume 14, Issue 2, February 2026.
Whey proteins possess antimicrobial and prebiotic properties that modulate gut microbiota by promoting beneficial bacteria like Bifidobacterium while suppressing pathogens. This modulation enhances short‐chain fatty acid production and strengthens intestinal barrier integrity, potentially alleviating dysbiosis‐related conditions such as colitis and ...
Tolulope Joshua Ashaolu, Chi‐Ching Lee, Ozgur Tarhan, Ali Rashidinejad, Seid Mahdi Jafari   +4 more
wiley   +1 more source

Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics. [PDF]

Antibiotics (Basel)
Santamaría-Corral G, Aguilera-Correa JJ, Esteban J, García-Quintanilla M.   +3 more
europepmc   +1 more source